DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 86 filers reported holding DESIGN THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $141,002 | -6.7% | 42,090 | +12.2% | 0.00% | – |
| Q1 2024 | $151,125 | +52.1% | 37,500 | 0.0% | 0.00% | – |
| Q4 2023 | $99,375 | +1.7% | 37,500 | -9.4% | 0.00% | – |
| Q3 2023 | $97,704 | -62.5% | 41,400 | 0.0% | 0.00% | – |
| Q2 2023 | $260,820 | +44.9% | 41,400 | +32.7% | 0.00% | – |
| Q1 2023 | $180,024 | -36.4% | 31,200 | +13.0% | 0.00% | – |
| Q4 2022 | $283,176 | -20.0% | 27,600 | +30.2% | 0.00% | – |
| Q3 2022 | $354,000 | +80.6% | 21,200 | +51.4% | 0.00% | – |
| Q2 2022 | $196,000 | – | 14,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 6,526,476 | $41,116,799 | 17.73% |
| Logos Global Management LP | 2,797,501 | $17,624,256 | 2.40% |
| Cormorant Asset Management, LP | 5,150,000 | $32,445,000 | 1.82% |
| RA Capital Management | 2,971,231 | $18,718,755 | 0.35% |
| Avoro Capital Advisors LLC | 3,500,000 | $22,050,000 | 0.30% |
| RTW INVESTMENTS, LP | 1,563,031 | $9,847,095 | 0.19% |
| GSA CAPITAL PARTNERS LLP | 238,200 | $1,501 | 0.15% |
| Virtus ETF Advisers LLC | 20,137 | $126,863 | 0.08% |
| Rock Springs Capital Management LP | 460,391 | $2,900,463 | 0.07% |
| Corton Capital Inc. | 17,323 | $109,135 | 0.05% |